Hancock Whitney Corp Edwards Lifesciences Corp Transaction History

Hancock Whitney Corp

$3.07 Billion
Q3 2024

A detailed history of Hancock Whitney Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Hancock Whitney Corp holds 30,741 shares of EW stock, worth $2.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

30,741

Previous 30,833 0.3%

Holding current value

$2.3 Million

Previous $2.85 Million 28.79%

% of portfolio

0.07%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $5,492 - $8,627	-92 Reduced 0.3%	30,741 $2.03 Million
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $28,240 - $31,593	-335 Reduced 1.07%	30,833 $2.85 Million
Q1 2024 May 16, 2024	SELL	$72.54 - $95.56 $152,986 - $201,536	-2,109 Reduced 6.34%	31,168 $2.98 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $77,507 - $97,666	-1,256 Reduced 3.64%	33,277 $2.54 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $225,506 - $303,951	-3,255 Reduced 8.61%	34,533 $2.39 Million
Q2 2023 Nov 13, 2023	SELL	$81.41 - $94.33 $454,104 - $526,172	-5,578 Reduced 12.86%	37,788 $3.56 Million
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $454,104 - $526,172	-5,578 Reduced 12.86%	37,788 $3.56 Million
Q1 2023 Nov 13, 2023	SELL	$74.26 - $84.51 $809,953 - $921,750	-10,907 Reduced 20.1%	43,366 $3.59 Million
Q1 2023 May 16, 2023	SELL	$74.26 - $84.51 $809,953 - $921,750	-10,907 Reduced 20.1%	43,366 $3.59 Million
Q4 2022 Nov 13, 2023	BUY	$68.3 - $87.44 $1.13 Million - $1.44 Million	16,485 Added 43.62%	54,273 $4.05 Million
Q4 2022 Feb 03, 2023	SELL	$68.3 - $87.44 $9.6 Million - $12.3 Million	-140,504 Reduced 72.14%	54,273 $4.05 Million
Q3 2022 Oct 26, 2022	SELL	$82.37 - $107.29 $485,406 - $632,259	-5,893 Reduced 2.94%	194,777 $16.1 Million
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $380,340 - $564,003	-4,397 Reduced 2.14%	200,670 $19.1 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $88,195 - $111,014	-865 Reduced 0.42%	205,067 $24.1 Million
Q4 2021 Jan 25, 2022	BUY	$106.37 - $130.68 $126,367 - $155,247	1,188 Added 0.58%	205,932 $26.7 Million
Q3 2021 Nov 04, 2021	SELL	$102.91 - $122.75 $778,205 - $928,235	-7,562 Reduced 3.56%	204,744 $23.2 Million
Q2 2021 Aug 09, 2021	SELL	$83.84 - $104.76 $189,562 - $236,862	-2,261 Reduced 1.05%	212,306 $22 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $357,757 - $412,276	-4,547 Reduced 2.08%	214,567 $17.9 Million
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $185,103 - $235,555	-2,582 Reduced 1.16%	219,114 $20 Million
Q3 2020 Nov 05, 2020	SELL	$67.19 - $87.44 $210,707 - $274,211	-3,136 Reduced 1.39%	221,696 $17.7 Million
Q2 2020 Jul 30, 2020	BUY	$57.54 - $76.95 $8.39 Million - $11.2 Million	145,803 Added 184.49%	224,832 $15.5 Million
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $14,465 - $22,356	276 Added 0.35%	79,029 $14.9 Million
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $882,770 - $1.01 Million	12,312 Added 18.53%	78,753 $18.4 Million
Q3 2019 Oct 29, 2019	SELL	$61.55 - $75.43 $103,219 - $126,496	-1,677 Reduced 2.46%	66,441 $14.6 Million
Q2 2019 Aug 29, 2019	SELL	$55.74 - $64.41 $230,819 - $266,721	-4,141 Reduced 5.73%	68,118 $12.6 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $99,515 - $133,095	-2,078 Reduced 2.8%	72,259 $13.8 Million
Q4 2018 Feb 15, 2019	SELL	$46.41 - $56.94 $600,545 - $736,803	-12,940 Reduced 14.83%	74,337 $11.4 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $3.99 Million - $5.06 Million	87,277 New	87,277 $15.2 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account

Hancock Whitney Corp Edwards Lifesciences Corp Transaction History